Invagen Pharms patents expiration
1. Leuprolide Acetate For Depot Suspension patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9789064 | INVAGEN PHARMS | Method for delivering a peptide to a subject at a modulated rate via microcapsules of lactic-co-glycolic copolymer containing said peptide |
Dec, 2020
(3 years ago) | |
Drugs and Companies using LEUPROLIDE ACETATE ingredient
Market Authorisation Date: 28 August, 2018
Treatment: NA
Dosage: FOR SUSPENSION;INTRAMUSCULAR
More Information on Dosage
LEUPROLIDE ACETATE FOR DEPOT SUSPENSION family patents
